CHIODELLI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 3.730
EU - Europa 2.006
AS - Asia 1.751
SA - Sud America 361
Continente sconosciuto - Info sul continente non disponibili 117
AF - Africa 36
OC - Oceania 28
Totale 8.029
Nazione #
US - Stati Uniti d'America 3.614
PL - Polonia 946
SG - Singapore 635
CN - Cina 522
BR - Brasile 289
UA - Ucraina 204
IT - Italia 200
DE - Germania 165
VN - Vietnam 161
HK - Hong Kong 159
FI - Finlandia 109
FR - Francia 80
GB - Regno Unito 78
TR - Turchia 59
CA - Canada 47
BD - Bangladesh 46
IE - Irlanda 43
RU - Federazione Russa 42
IN - India 39
AR - Argentina 27
AU - Australia 27
ID - Indonesia 23
JP - Giappone 20
SE - Svezia 20
AT - Austria 18
BE - Belgio 18
MX - Messico 18
CZ - Repubblica Ceca 17
ES - Italia 15
NL - Olanda 14
ZA - Sudafrica 13
VE - Venezuela 12
AE - Emirati Arabi Uniti 9
CL - Cile 9
CR - Costa Rica 9
EC - Ecuador 9
IQ - Iraq 9
LT - Lituania 8
PK - Pakistan 8
JO - Giordania 7
MA - Marocco 7
AZ - Azerbaigian 6
IL - Israele 6
NI - Nicaragua 6
SA - Arabia Saudita 6
EE - Estonia 5
GP - Guadalupe 5
PA - Panama 5
PR - Porto Rico 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
CO - Colombia 4
GT - Guatemala 4
MY - Malesia 4
CH - Svizzera 3
CY - Cipro 3
HN - Honduras 3
IR - Iran 3
JM - Giamaica 3
KZ - Kazakistan 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
SV - El Salvador 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
ZM - Zambia 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
KI - Kiribati 1
LU - Lussemburgo 1
NP - Nepal 1
Totale 7.913
Città #
Warsaw 944
Ashburn 402
Singapore 315
Fairfield 313
San Jose 200
Woodbridge 180
Hong Kong 158
Houston 157
Jacksonville 149
Chandler 139
Cambridge 131
Ann Arbor 120
Seattle 118
Council Bluffs 115
Beijing 113
Wilmington 108
New York 92
The Dalles 90
Los Angeles 84
Princeton 80
Helsinki 75
Brescia 68
Dallas 63
Munich 56
Nanjing 45
Ho Chi Minh City 43
Dong Ket 40
Dublin 40
Istanbul 40
Lauterbourg 40
Santa Clara 40
Dearborn 37
São Paulo 36
Chicago 29
San Francisco 28
Buffalo 25
Columbus 25
Hanoi 25
Phoenix 25
Shanghai 24
Milan 23
San Diego 20
Tokyo 19
Brussels 18
Redondo Beach 18
Des Moines 17
Jakarta 17
Atlanta 16
Jinan 16
Turku 16
Brooklyn 15
London 15
Nuremberg 15
Hangzhou 14
Hebei 14
Orem 14
Stockholm 14
Montreal 13
Denver 12
Moscow 12
Nanchang 12
Guangzhou 11
Jiaxing 11
Tianjin 11
Changsha 10
Johannesburg 10
North Bergen 10
Boardman 9
Brno 9
Dhaka 9
Frankfurt am Main 9
Leawood 9
San José 9
Zhengzhou 9
Amsterdam 8
Ankara 8
Chennai 8
Kocaeli 8
Mexico City 8
Shenyang 8
Toronto 8
Turin 8
Vienna 8
Haikou 7
Poplar 7
Rio de Janeiro 7
Baku 6
Managua 6
Manchester 6
Ningbo 6
Prague 6
Redwood City 6
Salt Lake City 6
Taizhou 6
Amman 5
Belo Horizonte 5
Charlotte 5
Curitiba 5
Kunming 5
Lancaster 5
Totale 5.439
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 375
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 329
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 326
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 318
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 295
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 286
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 262
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 237
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 229
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 197
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 195
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 192
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 190
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 183
Sialic acid as a target for the development of novel antiangiogenic strategies 181
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 178
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 169
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 161
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 155
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 154
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 153
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 151
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 148
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 146
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 142
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 139
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 135
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 134
Long-pentraxin 3 affects primary cilium in zebrafish embryo and cancer cells via the fgf system 130
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 125
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 124
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 120
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 117
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 116
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines 116
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 110
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma 107
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 97
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF THE INTERACTION OF GREMLIN (Drm) WITH HEPARIN/HEPARAN SULFATE PROTEOGLYCANS 93
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 92
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 89
Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis 89
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 84
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 83
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 81
Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells 72
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 72
implementation of an incremental docking method to study long sugar chains interactions with proteins 71
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 71
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 69
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 63
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 58
Involvement of N-formyl peptide receptors in modulating the pro-angiogenic/pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (PDR) 20
Totale 8.029
Categoria #
all - tutte 35.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022278 0 0 0 11 4 20 29 23 27 41 29 94
2022/2023391 52 8 20 16 32 96 5 42 62 2 32 24
2023/2024416 23 9 42 22 13 74 14 24 88 27 24 56
2024/20251.052 17 7 6 130 73 89 62 59 78 106 247 178
2025/20262.272 202 278 183 344 247 205 278 90 165 173 76 31
2026/2027562 62 92 170 238 0 0 0 0 0 0 0 0
Totale 8.029